Dara Wright - Dec 16, 2022 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role
Executive Vice President
Signature
/s/ Dara Wright
Stock symbol
BIO
Transactions as of
Dec 16, 2022
Transactions value $
-$92,203
Form type
4
Date filed
12/19/2022, 10:52 AM
Previous filing
Sep 7, 2022
Next filing
Sep 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIO Bio-Rad A Common Stock Options Exercise $0 +502 +33.78% $0.00 1.99K Dec 16, 2022 Direct F1, F2
transaction BIO Bio-Rad A Common Stock Tax liability -$92.2K -226 -11.37% $407.98 1.76K Dec 16, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIO Restricted Stock Units Options Exercise $0 -502 -33.31% $0.00 1.01K Dec 16, 2022 Bio-Rad A Common Stock 502 $0.00 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Class A common stock acquired on the vesting of restricted stock units.
F2 Includes 26.0150 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 09/30/2022.
F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F4 On December 16, 2019, the reporting person was granted 2,511 restricted stock units, vesting in 5 equal annual installments beginning on the first anniversary of the grant date.